Clinical Nurse Specialist in Kennewick, WA Accepting Medicare

3 Clinical Nurse Specialist nurses found. Showing 1 - 3

Brenda Diane Porco-smith, ARNP Clinical Nurse Specialist Medicare: Not Enrolled in Medicare Practice Location: 6710 W Okanogan Place, Kennewick, WA 99336 Phone: 509-783-2000    Fax: 509-783-2008

Ms. Tehea Kae Elsethagen, ARNP Clinical Nurse Specialist - Family Health Medicare: Not Enrolled in Medicare Practice Location: 10121 W Clearwater Ave, Suite 102, Kennewick, WA 99336 Phone: 509-783-4949

Renee Michelle Sullivan, RNFA Clinical Nurse Specialist - Perioperative Medicare: Not Enrolled in Medicare Practice Location: 1506 W 46th Ave, Kennewick, WA 99337 Phone: 509-586-4880

News Archive

Researchers identify specific influenza targets that could lead to universal flu vaccine for indigenous populations

Researchers have identified specific influenza targets that could be used to better protect Indigenous people from experiencing severe influenza disease through a universal, T cell-based vaccine.

Enrollment begins in Boston Scientific's vagal nerve stimulation trial for heart failure

Boston Scientific Corporation has enrolled the first patients in its NECTAR-HF (NEural Cardiac TherApy foR Heart Failure) clinical trial. NECTAR-HF is a prospective, randomized, international clinical feasibility study designed to assess preliminary safety and efficacy of chronic vagal nerve stimulation in heart failure patients.

Sociologists to explore ideas, scientific research relating to sexuality at ASA's Annual Meeting

More than 5,500 sociologists will convene in Chicago this August to explore ideas and scientific research relating to sexuality and many other topics, as part of the American Sociological Association's 110th Annual Meeting. This year's theme, "Sexualities in the Social World," shows the importance of research by sociologists in illuminating how social norms and social inequalities affect what sexual behavior is acceptable and who partners with whom.

FDA issues Complete Response Letter for approval of Eisai's rabeprazole sodium extended-release capsules

Eisai announced today that the company received a Complete Response Letter from the United States Food and Drug Administration (FDA) regarding the New Drug Application (NDA) of rabeprazole sodium extended-release capsules, 50 mg, an investigational proton pump inhibitor (PPI) under review for the healing and long-term maintenance of healing and symptom resolution of erosive gastroesophageal reflux disease (GERD), and for the treatment of daytime and nighttime heartburn and other symptoms of non-erosive GERD.

Read more Medical News

› Verified 8 days ago